Quantitative prediction of oral drug interactions caused by CYP3A4 inhibition for an extended panel of substrates and inhibitors

被引：0
|
作者：
Loue, C. [1 ]
Tod, M. [2 ]
机构：
[1] Hop Croix Rousse, F-69317 Lyon, France
[2] Univ Lyon 1, F-69365 Lyon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2013年 / 27卷
关键词：
drug-drug interaction; cyp3a4; quantitative prediction; pharmacokinetics;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] QUANTITATIVE PREDICTION OF CYP3A4 AND CYP3A5-MEDIATED DRUG DRUG INTERACTIONS
    Guo, Yingying
    Lucksiri, Aroonrut
    Dickinson, Gemma
    Vuppalanchi, Raj
    Hilligoss, Janna
    Huang, Shiew-Mei
    Hall, Stephen
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S43 - S44
  • [2] Quantitative prediction of CYP3A4 drug-drug interactions: Extending the strategy
    Galetin, A
    Hallifax, D
    Ito, K
    Houston, JB
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 62 - 62
  • [3] Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug-Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates
    Mano, Yoko
    Sugiyama, Yuichi
    Ito, Kiyomi
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (09) : 3183 - 3193
  • [4] General Framework for the Prediction of Oral Drug Interactions Caused by CYP3A4 Induction from In Vivo Information
    Yoshiyuki Ohno
    Akihiro Hisaka
    Masaki Ueno
    Hiroshi Suzuki
    [J]. Clinical Pharmacokinetics, 2008, 47 : 669 - 680
  • [5] General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information
    Ohno, Yoshiyuki
    Hisaka, Akihiro
    Ueno, Masaki
    Suzuki, Hiroshi
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (10) : 669 - 680
  • [6] CYP3A4 drug interactions:: correlation of 10 in vitro probe substrates
    Kenworthy, KE
    Bloomer, JC
    Clarke, SE
    Houston, JB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (05) : 716 - 727
  • [7] Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers
    Gabriel, Laurence
    Tod, Michel
    Goutelle, Sylvain
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (08) : 977 - 990
  • [8] Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers
    Laurence Gabriel
    Michel Tod
    Sylvain Goutelle
    [J]. Clinical Pharmacokinetics, 2016, 55 : 977 - 990
  • [9] CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactions
    Galetin, A
    Ito, K
    Hallifax, D
    Houston, JB
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (01): : 180 - 190
  • [10] Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability
    Fasinu, Pius
    Choonara, Yahya E.
    Khan, Riaz A.
    Du Toit, Lisa C.
    Kumar, Pradeep
    Ndesendo, Valence M. K.
    Pillay, Viness
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (02) : 541 - 555
12345